Mirna Chehade, MD, MPH, discusses the impact of adverse events on influencing treatment decisions for eosinophilic esophagitis (EoE) in pediatric patients, and considerations for the use of biologics.
Discover the immuno-pathophysiological similarities between long COVID and fatigue syndrome. Learn more about immunotherapy addressing both conditions.
Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.
Mirna Chehade, MD, MPH, outlines consequences that can stem from delay in diagnosis of eosinophilic esophagitis (EoE), as well as treatment goals, highlighting unique considerations for treatment in children.
Mirna Chehade, MD, MPH, discusses eosinophilic esophagitis (EoE), detailing its immune-mediated nature and age-dependent symptoms, emphasizing that in children, symptoms can manifest as feeding difficulties and failure to thrive.